Vericel Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
VCEL Nasdaq 2830 www.vcel.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vericel Corporation

Vericel (VCEL) Stock Looks Fully Priced After A 31% Gain - Sep 26th, 2026 4:06 pm
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026 - Sep 8th, 2026 6:30 am
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Aug 13th, 2026 5:00 am
Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison - Aug 3rd, 2026 8:55 am
Vericel Q2 Earnings Call Highlights - Jul 30th, 2026 3:03 pm
Vericel Corporation (VCEL) Beats Q2 Earnings and Revenue Estimates - Jul 30th, 2026 7:35 am
Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program - Jul 30th, 2026 5:55 am
Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026 - Jul 16th, 2026 6:30 am
Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests - Jun 27th, 2026 11:18 am
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026 - Jun 9th, 2026 6:30 am
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More - May 30th, 2026 12:59 pm